memantine has been researched along with Peripheral Nerve Diseases in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine hydrochloride, an NMDA antagonist, was launched in Germany by Merz in 1989 for the treatment of dementia, an indication for which development was continuing in other markets." | 4.81 | Memantine. Merz. ( Kilpatrick, GJ; Tilbrook, GS, 2002) |
| "Systemic treatment with the N-methyl-D-aspartate (NMDA) antagonist memantine (MEM) resulted in a decrease in mechanical hyperalgesia and mechanical allodynia in neuropathic rats." | 3.69 | Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. ( Carlton, SM; Hargett, GL, 1995) |
| "It is still unknown whether neuropathic pain could relate to behavioral and neurochemical alterations in the central nervous system." | 1.35 | Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain. ( Chikuma, T; Kato, T; Muramatsu, M; Takeda, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, K | 1 |
| Muramatsu, M | 1 |
| Chikuma, T | 1 |
| Kato, T | 1 |
| Nakazato, E | 1 |
| Kato, A | 1 |
| Watanabe, S | 1 |
| Schifitto, G | 1 |
| Yiannoutsos, CT | 1 |
| Simpson, DM | 1 |
| Marra, CM | 1 |
| Singer, EJ | 1 |
| Kolson, DL | 1 |
| Nath, A | 1 |
| Berger, JR | 1 |
| Navia, B | 1 |
| Carlton, SM | 1 |
| Hargett, GL | 1 |
| Suzuki, R | 1 |
| Matthews, EA | 1 |
| Dickenson, AH | 1 |
| Kilpatrick, GJ | 1 |
| Tilbrook, GS | 1 |
1 review available for memantine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Memantine. Merz.
Topics: Animals; Clinical Trials as Topic; Dementia; Excitatory Amino Acid Antagonists; Glaucoma; Humans; Me | 2002 |
1 trial available for memantine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
Topics: Adult; Excitatory Amino Acid Antagonists; Female; HIV; HIV Infections; Humans; Male; Memantine; Peri | 2006 |
4 other studies available for memantine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain.
Topics: Analgesics; Animals; Brain; CD11 Antigens; Disease Models, Animal; Excitatory Amino Acid Antagonists | 2009 |
Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
Topics: Analgesics; Animals; Brain Chemistry; Constriction; Excitatory Amino Acid Antagonists; Injections, I | 2005 |
Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats.
Topics: Analgesics; Animals; Drug Implants; Excitatory Amino Acid Antagonists; Hyperalgesia; Injections, Int | 1995 |
Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy.
Topics: Animals; Dizocilpine Maleate; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagon | 2001 |